Drug Interaction Database tools support clinical development workflows

The Drug Interaction Database (DIDB) is being utilized to streamline drug-drug interaction (DDI) risk assessments during the drug development process. The platform provides curated evidence, including in vitro metabolism and transporter data, clinical DDI studies, and pharmacogenetic information to support evidence-based decision-making.

In clinical trials, managing DDI risk is essential for patient safety and trial success. Tools such as the Concomitant Meds Navigator within the DIDB help researchers identify prohibited medications and align assessments with ICH M12 guidelines. By centralizing fragmented information from literature and regulatory documents, the database aims to improve consistency across development programs and reduce the need for protocol amendments.